SCHEMBL10153371

SCHEMBL10153371

O=CC=Nc1cc(Cl)cc(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
HTR3E A5X5Y0 2/20 0.38
HTR3B O95264 2/20 0.38
HTR3A P46098 2/20 0.38
HTR3D Q70Z44 2/20 0.38
HTR3C Q8WXA8 2/20 0.38
ERN1 O75460 2/20 0.33
ITGB3 P05106 1/20 0.33
ITGAV P06756 1/20 0.33
TPMT P51580 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
RECQL P46063 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153360 0.81 AHR (0.35) TSHRITGB3ITGAVCYP3A4ALDH1A1
SCHEMBL14459257 0.79 MAPT (0.50) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL85152 0.76 MAPT (0.47) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7092582 0.71 ALDH1A1 (0.38) TSHRERN1TPMTMEN1ALDH1A1
SCHEMBL14459252 0.71 KMT2A (0.58) TSHRHTR3EHTR3BHTR3AHTR3D
SCHEMBL13590027 0.71 S100B (0.50) TP53MEN1ALDH1A1MAPTKMT2A
SCHEMBL13590019 0.68 ALDH1A1 (0.37) CYP3A4MEN1ALDH1A1MAPTRECQL
SCHEMBL14459432 0.67 KMT2A (0.44) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL10153362 0.67 ITGB3 (0.39) HTR3EHTR3BHTR3AHTR3DHTR3C
1,3,5-Trichlorobenzene SCHEMBL27517784 0.67 TSHR (0.61) TSHRERN1TPMTTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329907-B2 Autotaxin inhibitors MERCK PATENT GMBH (DE) 2012-12-11 US disclosed
US-20120015976-A1 AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANK TER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015976-A1 AUTOTAXIN INHIBITORS ENPP2, PLA2G12A, LPCAT1 TSHR 1865/4885HTR3E 3836/4885HTR3B 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.